Common genetic variations of the cytochrome P450 1A1 gene and risk of hepatocellular carcinoma in a Chinese population

European Journal of Cancer

Volumn 45, Issue 7, 2009, Pages 1239-1247

  Li, Rui ^a   Shugart, Yin Yao ^b   Zhou, Weiping ^c   An, Yu ^a   Yang, Yuan ^c,d   Zhou, Yun ^d   Zhang, Beibei ^d   Lu, Daru ^a   Wang, Hongyang ^d   Qian, Ji ^a   Jin, Li ^a  

^a FUDAN UNIVERSITY   (China)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c Eastern Hepatobiliary Surgery Hospital   (China)

^d Eastern Institute of Hepatobiliary Surgery   (China)

Author keywords

CYP1A1; Genetic polymorphism; Haplotype; Hepatitis; Hepatocellular carcinoma

Indexed keywords

CYTOCHROME P450 1A1;

ADULT; AGED; ARTICLE; CANCER RISK; CHINESE; CONTROLLED STUDY; FEMALE; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HOMOZYGOSITY; HUMAN; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING HABIT;

ADULT; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; CARCINOMA, HEPATOCELLULAR; CASE-CONTROL STUDIES; CYTOCHROME P-450 CYP1A1; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HUMANS; LIVER NEOPLASMS; LOGISTIC MODELS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK; SMOKING;

EID: 64049116251     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2008.11.007     Document Type: Article

References (35)

1. Bosch F.X., Ribes J., Diaz M., and Cleries R. Primary liver cancer: worldwide incidence and trends. Gastroenterology 127 5 Suppl 1 (2004) S5-S16
2. Parkin D.M., Bray F., Ferlay J., and Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 55 2 (2005) 74-108
3. Hertl M., and Cosimi A.B. Liver transplantation for malignancy. Oncologist 10 4 (2005) 269-281
4. Farazi P.A., and DePinho R.A. Hepatocellular carcinoma pathogenesis: from genes to environment. Nat Rev Cancer 6 9 (2006) 674-687
5. Chen C.J., Yu M.W., and Liaw Y.F. Epidemiological characteristics and risk factors of hepatocellular carcinoma. J Gastroenterol Hepatol 12 9-10 (1997) S294-S308
6. Chen S.Y., Wang L.Y., Lunn R.M., et al. Polycyclic aromatic hydrocarbon-DNA adducts in liver tissues of hepatocellular carcinoma patients and controls. Int J Cancer 99 1 (2002) 14-21
7. Wu H.C., Wang Q., Wang L.W., et al. Polycyclic aromatic hydrocarbon- and aflatoxin-albumin adducts, hepatitis B virus infection and hepatocellular carcinoma in Taiwan. Cancer Lett 252 1 (2007) 104-114
8. Staal Y.C., van Herwijnen M.H., Pushparajah D.S., et al. Modulation of gene expression and DNA-adduct formation in precision-cut liver slices exposed to polycyclic aromatic hydrocarbons of different carcinogenic potency. Mutagenesis 22 1 (2007) 55-62
9. Kawajiri K., Watanabe J., Gotoh O., Tagashira Y., Sogawa K., and Fujii-Kuriyama Y. Structure and drug inducibility of the human cytochrome P-450c gene. Eur J Biochem 159 2 (1986) 219-225
10. Yu M.W., Chiu Y.H., Yang S.Y., et al. Cytochrome P450 1A1 genetic polymorphisms and risk of hepatocellular carcinoma among chronic hepatitis B carriers. Brit J Cancer 80 3-4 (1999) 598-603
11. Silvestri L., Sonzogni L., De Silvestri A., et al. CYP enzyme polymorphisms and susceptibility to HCV-related chronic liver disease and liver cancer. Int J Cancer 104 3 (2003) 310-317
12. Smart J., and Daly A.K. Variation in induced CYP1A1 levels: relationship to CYP1A1, Ah receptor and GSTM1 polymorphisms. Pharmacogenetics 10 1 (2000) 11-24
13. Ryder S.D. Guidelines for the diagnosis and treatment of hepatocellular carcinoma (HCC) in adults. Gut 52 Suppl 3 (2003) iii1-iii8
14. Carlson C.S., Eberle M.A., Rieder M.J., Yi Q., Kruglyak L., and Nickerson D.A. Selecting a maximally informative set of single-nucleotide polymorphisms for association analyses using linkage disequilibrium. Am J Hum Genet 74 1 (2004) 106-120
15. Song N., Tan W., Xing D.Y., and Lin D.X. CYP 1A1 polymorphism and risk of lung cancer in relation to tobacco smoking: a case-control study in China. Carcinogenesis 22 1 (2001) 11-16
16. Park J.Y., Muscat J.E., Ren Q., et al. CYP1A1 and GSTM1 polymorphisms and oral cancer risk. Cancer Epidemiol Biomarkers Prev 6 10 (1997) 791-797
17. Nyholt D.R. A simple correction for multiple testing for single-nucleotide polymorphisms in linkage disequilibrium with each other. Am J Hum Genet 74 4 (2004) 765-769
18. Schaid D.J., Rowland C.M., Tines D.E., Jacobson R.M., and Poland G.A. Score tests for association between traits and haplotypes when linkage phase is ambiguous. Am J Hum Genet 70 2 (2002) 425-434
19. Stephens M., and Donnelly P. A comparison of bayesian methods for haplotype reconstruction from population genotype data. Am J Hum Genet 73 5 (2003) 1162-1169
20. Stiborova M., Martinek V., Rydlova H., Koblas T., and Hodek P. Expression of cytochrome P450 1A1 and its contribution to oxidation of a potential human carcinogen 1-phenylazo-2-naphthol (Sudan I) in human livers. Cancer Lett 220 2 (2005) 145-154
21. Roberts-Thomson S.J., McManus M.E., Tukey R.H., Gonzalez F.F., and Holder G.M. The catalytic activity of four expressed human cytochrome P450s towards benzo[a]pyrene and the isomers of its proximate carcinogen. Biochem Biophys Res Commun 192 3 (1993) 1373-1379
22. Moennikes O., Loeppen S., Buchmann A., et al. A constitutively active dioxin/aryl hydrocarbon receptor promotes hepatocarcinogenesis in mice. Cancer Res 64 14 (2004) 4707-4710
23. Trinklein N.D., Aldred S.F., Hartman S.J., Schroeder D.I., Otillar R.P., and Myers R.M. An abundance of bidirectional promoters in the human genome. Genome Res 14 1 (2004) 62-66
24. Ueda R., Iketaki H., Nagata K., et al. A common regulatory region functions bidirectionally in transcriptional activation of the human CYP1A1 and CYP1A2 genes. Mol Pharmacol 69 6 (2006) 1924-1930
25. Chen X., Wang H., Xie W., et al. Association of CYP1A2 genetic polymorphisms with hepatocellular carcinoma susceptibility: a case-control study in a high-risk region of China. Pharmacogenet Genomics 16 3 (2006) 219-227
26. Sakata Y., Yoshioka W., Tohyama C., and Ohsako S. Internal genomic sequence of human CYP1A1 gene is involved in superinduction of dioxin-induced CYP1A1 transcription by cycloheximide. Biochem Biophys Res Commun 355 3 (2007) 687-692
27. Yuan H.Y., Chiou J.J., Tseng W.H., et al. FASTSNP: an always up-to-date and extendable service for SNP function analysis and prioritization. Nucleic Acids Res 34 Web Server issue (2006) W635-W641
28. Leung Y.K., Lau K.M., Mobley J., Jiang Z., and Ho S.M. Overexpression of cytochrome P450 1A1 and its novel spliced variant in ovarian cancer cells: alternative subcellular enzyme compartmentation may contribute to carcinogenesis. Cancer Res 65 9 (2005) 3726-3734
29. Taioli E., Ford J., Trachman J., Li Y., Demopoulos R., and Garte S. Lung cancer risk and CYP1A1 genotype in African Americans. Carcinogenesis 19 5 (1998) 813-817
30. Ishibe N., Wiencke J.K., Zuo Z.F., McMillan A., Spitz M., and Kelsey K.T. Susceptibility to lung cancer in light smokers associated with CYP1A1 polymorphisms in Mexican- and African-Americans. Cancer Epidemiol Biomarkers Prev 6 12 (1997) 1075-1080
31. Vineis P., Kogevinas M., Simonato L., Brennan P., and Boffetta P. Levelling-off of the risk of lung and bladder cancer in heavy smokers: an analysis based on multicentric case-control studies and a metabolic interpretation. Mutat Res 463 1 (2000) 103-110
32. Vineis P., Bartsch H., Caporaso N., et al. Genetically based N-acetyltransferase metabolic polymorphism and low-level environmental exposure to carcinogens. Nature 369 6476 (1994) 154-156
33. Vineis P., Alavanja M., and Garte S. Dose-response relationship in tobacco-related cancers of bladder and lung: a biochemical interpretation. Int J Cancer 108 1 (2004) 2-7
34. Xu S., and Jin L. A genome-wide analysis of admixture in Uyghurs and a high-density admixture map for disease-gene discovery. Am J Hum Genet 83 3 (2008) 322-336
35. Pritchard J.K., and Donnelly P. Case-control studies of association in structured or admixed populations. Theor Popul Biol 60 3 (2001) 227-237